Source:http://linkedlifedata.com/resource/pubmed/id/20182036
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-5-7
|
pubmed:abstractText |
Alzheimer's disease has emerged in recent decades as a major health problem and the role of lifestyles in the modulation of risk has been increasingly recognized. Recent epidemiological studies suggest a protective effect for caffeine intake in dementia. We aimed to quantify the association between caffeine dietary intake and cognitive decline, in a cohort of adults living in Porto. A cohort of 648 subjects aged > or =65 years was recruited between 1999-2003. Follow-up evaluation (2005-2008) was carried out on 58.2% of the eligible participants and 10.9% were deceased. Caffeine exposure in the year preceding baseline evaluation was assessed with a validated food frequency questionnaire. Cognitive evaluation consisted of baseline and follow-up Mini-Mental State Examination (MMSE). Cognitive decline was defined by a decrease > or =2 points in the MMSE score between evaluations. Relative risk (RR) and 95% confidence interval (95%CI) estimates adjusted for age, education, smoking, alcohol drinking, body mass index, hypertension, and diabetes were computed using Poisson regression. Caffeine intake (> 62 mg/day [3rd third] vs. < 22 mg/day [1st third]) was associated with a lower risk of cognitive decline in women (RR=0.49, 95%CI 0.24-0.97), but not significantly in men (RR=0.65, 95%CI 0.27-1.54). Our study confirms the negative association between caffeine and cognitive decline in women.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1875-8908
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S175-85
|
pubmed:meshHeading |
pubmed-meshheading:20182036-Aged,
pubmed-meshheading:20182036-Caffeine,
pubmed-meshheading:20182036-Central Nervous System Stimulants,
pubmed-meshheading:20182036-Coffee,
pubmed-meshheading:20182036-Cognition Disorders,
pubmed-meshheading:20182036-Cohort Studies,
pubmed-meshheading:20182036-Confidence Intervals,
pubmed-meshheading:20182036-Female,
pubmed-meshheading:20182036-Humans,
pubmed-meshheading:20182036-Male,
pubmed-meshheading:20182036-Mental Status Schedule,
pubmed-meshheading:20182036-Neuropsychological Tests,
pubmed-meshheading:20182036-Portugal,
pubmed-meshheading:20182036-Questionnaires,
pubmed-meshheading:20182036-Regression Analysis,
pubmed-meshheading:20182036-Retrospective Studies,
pubmed-meshheading:20182036-Risk Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal.
|
pubmed:affiliation |
Department of Hygiene and Epidemiology, Porto University Medical School and Institute of Public Health, University of Porto (ISPUP), Porto, Portugal. catarinasantos@portugalmail.pt
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|